Figure 2: Categorization of Samples Analyzed (IMAGE)
Caption
(A) Number of samples rejected and processed; (B) Patients with treatment options (approved for the cancer type analyzed, approved for other cancer types or under development) and without, according to test; (C) The potential or lack of potential or the unknown potential clinical benefit of samples, according to test and cancer type. PCB, potential clinical benefit.
Credit
Jean-François Laes, email: jf.laes@oncodna.com
Usage Restrictions
None
License
Licensed content